BioSpace News Archive

Ever since the discovery of DNA, scientists have raced to understand which tiny variations among the 3 billion base pairs within the human genome are responsible for causing disease.

National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its first quarter dividend of $1.1025 per common share on May 7, 2021 to shareholders of record as of March 31, 2021.

Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) today announces that it is changing its fiscal year-end to December 31, from its current fiscal year-end of April 30. The notice for the year-end change required under National Instrument 51-102 has been filed under the Company’s profile at www.sedar.com.

InnovAge Holding Corp. (Nasdaq: INNV) today announced that on March 9, 2021, the underwriters of the previously announced initial public offering of 16,666,667 shares of its common stock exercised their option to purchase an additional 2,329,234 shares of common stock from InnovAge at the initial public offering price of $21.00 per share, less underwriting discounts and commissions

MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX), a global leader in teledermatology, announces that two of its long-standing directors have announced their intention to retire from the Board.